BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $125,995,000 | +215.5% | 833,464 | +204.2% | 0.06% | +243.8% |
| Q2 2022 | $39,929,000 | +794.9% | 274,026 | +628.2% | 0.02% | +1500.0% |
| Q1 2022 | $4,462,000 | +175.6% | 37,629 | +220.4% | 0.00% | – |
| Q4 2021 | $1,619,000 | +93.0% | 11,746 | +94.3% | 0.00% | – |
| Q3 2021 | $839,000 | +90.2% | 6,045 | +33.2% | 0.00% | – |
| Q2 2021 | $441,000 | -83.6% | 4,539 | -88.5% | 0.00% | -100.0% |
| Q1 2021 | $2,690,000 | -13.9% | 39,360 | +8.0% | 0.00% | 0.0% |
| Q4 2020 | $3,125,000 | +218.2% | 36,460 | +141.4% | 0.00% | – |
| Q3 2020 | $982,000 | +591.5% | 15,103 | +677.3% | 0.00% | – |
| Q2 2020 | $142,000 | +264.1% | 1,943 | +69.3% | 0.00% | – |
| Q1 2020 | $39,000 | -27.8% | 1,148 | +16.7% | 0.00% | – |
| Q4 2019 | $54,000 | -98.7% | 984 | -99.0% | 0.00% | -100.0% |
| Q3 2019 | $4,275,000 | +1315.6% | 102,479 | +1384.6% | 0.00% | – |
| Q2 2019 | $302,000 | +40.5% | 6,903 | +65.3% | 0.00% | – |
| Q1 2019 | $215,000 | -54.2% | 4,177 | -67.1% | 0.00% | – |
| Q4 2018 | $469,000 | -11.0% | 12,678 | -9.6% | 0.00% | – |
| Q3 2018 | $527,000 | +296.2% | 14,021 | +317.3% | 0.00% | – |
| Q2 2018 | $133,000 | +121.7% | 3,360 | +45.2% | 0.00% | – |
| Q1 2018 | $60,000 | -13.0% | 2,314 | -9.6% | 0.00% | – |
| Q4 2017 | $69,000 | +392.9% | 2,559 | +593.5% | 0.00% | – |
| Q3 2017 | $14,000 | – | 369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |